MeMed
At MeMed, a leader in host response technologies, we decode the body’s complex signals into simple insights that improve people’s lives.
By leveraging our expertise in host-response profiling and machine-learning algorithms, we have developed a point-of-need, rapid measurement platform called MeMed Key® to ensure timely availability of these novel tests during the clinician’s decision-making workflow.
Run on the MeMed Key, MeMed BV® is an FDA-cleared host-immune response assay that can aid to distinguish between bacterial and viral infections, delivering fast and accurate results in 15 minutes from a serum or venous whole blood sample. This enables physicians to make faster, more informed decisions.
MeMed BV was clinically validated in multiple multinational, double-blind clinical studies and real-world usage encompassing >20,000 patients and is also CE-IVD and AMAR cleared.
Note: MeMed BV on whole blood is 510K cleared and currently available only for the US market.